RUSSO, GIANLUCA
 Distribuzione geografica
Continente #
AS - Asia 2.117
EU - Europa 1.465
NA - Nord America 1.028
SA - Sud America 237
AF - Africa 33
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.885
Nazione #
SG - Singapore 1.124
US - Stati Uniti d'America 968
RU - Federazione Russa 659
CN - Cina 479
IT - Italia 434
HK - Hong Kong 240
BR - Brasile 193
DE - Germania 126
VN - Vietnam 103
IN - India 57
GB - Regno Unito 48
NL - Olanda 46
KR - Corea 43
FI - Finlandia 34
MX - Messico 24
CA - Canada 23
ES - Italia 22
AR - Argentina 20
UA - Ucraina 17
FR - Francia 16
BD - Bangladesh 15
PL - Polonia 14
EC - Ecuador 10
JP - Giappone 10
ZA - Sudafrica 9
AT - Austria 8
IE - Irlanda 8
IQ - Iraq 8
CI - Costa d'Avorio 7
SE - Svezia 7
PK - Pakistan 6
VE - Venezuela 6
BE - Belgio 5
ID - Indonesia 5
LT - Lituania 5
TR - Turchia 4
AU - Australia 3
BS - Bahamas 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
GA - Gabon 1
HU - Ungheria 1
JM - Giamaica 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
YT - Mayotte 1
Totale 4.885
Città #
Singapore 634
Hong Kong 239
Hefei 222
Moscow 138
Ashburn 115
Beijing 113
Chandler 113
Naples 98
Santa Clara 62
Munich 51
Los Angeles 47
Ho Chi Minh City 42
Seoul 42
Milan 41
Kochi 38
Rome 34
New York 28
São Paulo 28
Redondo Beach 24
Dallas 20
Lawrence 20
Buffalo 19
Helsinki 18
Hanoi 16
Des Moines 15
Millbury 15
Amsterdam 14
Boston 14
Mexico City 14
Boardman 12
The Dalles 12
Chicago 11
Poplar 11
Turku 11
Warsaw 10
Bologna 9
Frankfurt am Main 9
London 9
Orem 9
Seattle 9
Valencia 9
Falkenstein 8
Florence 8
Montreal 8
Nuremberg 8
Tokyo 8
Wilmington 8
Atlanta 7
Bari 7
Brooklyn 7
Da Nang 7
Genoa 7
Haiphong 7
Krefeld 7
Rio de Janeiro 7
Stockholm 7
Chennai 6
Denver 6
Düsseldorf 6
Guangzhou 6
Houston 6
San Francisco 6
Dublin 5
Hải Dương 5
Lappeenranta 5
Phoenix 5
Salt Lake City 5
Shanghai 5
Buenos Aires 4
Charlotte 4
Cilavegna 4
Council Bluffs 4
Johannesburg 4
Madrid 4
Monza 4
Ninh Bình 4
Sciacca 4
Tianjin 4
Toronto 4
Turin 4
Amman 3
Bad Durrheim 3
Belo Horizonte 3
Berlin 3
Bexley 3
Brasília 3
Brussels 3
Casalnuovo di Napoli 3
Cuenca 3
Curitiba 3
Fairfield 3
Fisciano 3
Grosseto 3
Guarulhos 3
Karachi 3
Kronberg 3
Lucca 3
Macerata 3
Mercato San Severino 3
Montalto di Castro 3
Totale 2.680
Nome #
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 159
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 126
Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 126
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 124
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 119
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 117
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 116
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 115
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 114
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 114
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 113
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 109
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 105
The role of liquid biopsy in epithelial ovarian cancer: state of the art 103
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 103
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 102
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 101
Brca1/2 ngs somatic testing in clinical practice: a short report 100
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer 100
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 99
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 99
The evolving role of liquid biopsy in lung cancer 98
Next generation sequencing in cytology 98
Methods for actionable gene fusion detection in lung cancer: now and in the future 97
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 96
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 94
Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study 93
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 92
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 91
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 90
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 89
Tumor mutational burden on cytological samples: A pilot study 88
BRAF: A Two-Faced Janus 88
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 88
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 85
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 80
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 80
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 79
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 78
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 76
Critical aspects of MSI testing in endometrial cancer: a comparison study 75
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 74
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 70
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 69
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 66
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 60
Genomics and the early diagnosis of lung cancer 60
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 59
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 59
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 56
Liquid biopsy testing in urological cancers: Focus on urine 54
Smaller, cheaper, faster: where next for liquid biopsies? 52
Mutational profiling of SMARCA4 and SMARCB1 in ampullary adenocarcinoma: a preliminary study 44
Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution 43
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 32
The potential application of stroma modulation in targeting tumor cells: focus on pancreatic cancer and breast cancer models 21
Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study 16
Totale 4.954
Categoria #
all - tutte 14.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 11 5 12 7 9 6 6
2021/2022173 6 5 12 2 3 3 3 15 1 25 55 43
2022/2023300 26 14 17 12 46 41 1 34 45 20 41 3
2023/2024301 10 42 17 16 20 18 13 34 17 33 40 41
2024/20251.598 54 58 6 17 38 92 141 115 81 205 586 205
2025/20262.526 350 449 438 390 705 194 0 0 0 0 0 0
Totale 4.954